Benzinga - by David Pinsen, Benzinga Contributor.
Another RSI Buy In a post last month, we wrote about the power of RSI (Relative Strength Index) as a technical indicator (Relative Strength Index) in relation to Stitch Fix, Inc. (NASDAQ: SFIX)
A technical indicator to keep in mind for earnings trades. https://t.co/g6zISKkVmc$BIG $SFIXAnd in a post earlier this month, we wrote about An Oversold Gold Miner, in light of the recent dynamic in the SPDR Gold Shares ETF (ARCA:GLD).— Portfolio Armor (@PortfolioArmor) September 25, 2023
An oversold gold miner. $GLD $GDX $BIIB $RETA https://t.co/Cq0UqqIiALSince we wrote that second post, shares of that gold miner are up 13%, and our options trade on it is up 50%. And that's before that company reports earnings next month. The industrial stock we're writing about today releases earnings later this week. Let's quickly recap what RSI is, and then look at why we're betting on this industrial now.— Portfolio Armor (@PortfolioArmor) October 5, 2023
An Oversold Industrial Recall that RSI is a number from 0 to 100 indicating how overbought or oversold a security is. Values over 70 are usually considered overbought, and values below 30 are usually considered oversold.
One screen we’ve been looking at recently includes both RSI and the Piotroski F-Score, which is a measure of financial strength on a scale from 0-9, with 9 being best. We run a bearish version of that where we look for stocks with an RSI over 80 and a Piotroski F-Score of 2 or lower, and we run a bullish one where I look for an RSI under 20 and an F-Score of 8 or better.
An industrial stock comes up on this screen now, one with an F-Score of 8 and an RSI below 20.
Digging Deeper As with all mechanical screens, it’s best to do some further investigation, to eliminate false positives. For example, one of the stocks the bearish version of this screen picked up recently was Reata Pharmaceuticals (DEFUNCT:RETA) where the RSI looks high because the company was just acquired by Biogen, Inc. (NASDAQ: BIIB).
Digging deeper into our oversold industrial, we find that its fundamentals are strong, except for growth stability.
In this case, the relatively weak growth stability is an artifact of the COVID lockdowns: this is one of those companies that saw demand pulled forward during the pandemic, and a subsequent softening after.
A Big Collapse After Mixed Earnings Last Quarter In July, the company beat on earnings but missed on revenue, and, more importantly, offered significantly lower forward guidance driven by market weakness. In response, the shares plummeted about 25%.
Here's Where It Gets Interesting After that share collapse, no insiders sold; instead, five of them--all directors, including the chairman of the board--bought more shares in the open market. And two of those directors bought even more shares two weeks ago.
Think about that for a moment. The company's 3rd quarter ended on September 30th. Presumably, those directors had some inkling of how the company did in that quarter, and they decided to buy more shares.
And now you can buy those shares for ~24% less than what those directors paid.
Except we're not going to do that. We're going to spend even less, by buying options on the stock. As oversold as it is (remember, an RSI below 20), when the company reports earnings this week, if those earnings are less terrible than the market has already priced in, the stock could bounce. And if it does, our options will bounce even higher.
If you'd like a heads up when we place that options trade, feel free to subscribe to our trading Substack/occasional email list below.
If You Want To Stay In Touch
You can scan for optimal hedges for individual securities, find our current top ten names, and create hedged portfolios on our website. You can also follow Portfolio Armor on Twitter here, or become a free subscriber to our trading Substack using the link below (we're using that for our occasional emails now).
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.